1
|
Shen Y, Liang LZ, Hong MH, Xiong Y, Wei M
and Zhu XF: Expression and clinical significance of
microtubule-associated protein 1 light chain 3 (LC3) and Beclin 1
in epithelial ovarian cancer. Ai Zheng. 27:595–599. 2008.In
Chinese. PubMed/NCBI
|
2
|
Liang XH, Kleeman LK, Jiang HH, Gordon G,
Goldman JE, Berry G, Herman B and Levine B: Protection against
fatal Sindbis virus encephalitis by Beclin, a novel
Bcl-2-interacting protein. J Virol. 72:8586–8596. 1998.PubMed/NCBI
|
3
|
Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh
H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y, et al:
Promotion of tumorigenesis by heterozygous disruption of the beclin
1 autophagy gene. J Clin Invest. 112:1809–1820. 2003. View Article : Google Scholar : PubMed/NCBI
|
4
|
Kanzawa T, Germano IM, Komata T, Ito H,
Kondo Y and Kondo S: Role of autophagy in temozolomide induced
cytotoxicity for malignant glioma cells. Cell Death Differ.
11:448–457. 2004. View Article : Google Scholar : PubMed/NCBI
|
5
|
Yue Z, Jin S, Yang C, Levine AJ and Heintz
N: Beclin 1, an autophagy gene essential for early embronic
development, is a haploinsufficient tumor suppressor. Proc Natl
Acad Sci USA. 100:15077–15282. 2003. View Article : Google Scholar
|
6
|
Wang W, Fan H, Zhou Y, Duan P, Zhao G and
Wu G: Knockdown of autophagy-related gene BECLIN1 promotes cell
growth and inhibits apoptosis in the A549 human lung cancer cell
line. Mol Med Rep. 7:1501–1505. 2013.PubMed/NCBI
|
7
|
Lockshin RA and Zakeri Z:
Caspase-independent cell deaths. Curr Opin Cell Biol. 14:727–733.
2002. View Article : Google Scholar : PubMed/NCBI
|
8
|
Jia L, Dourmashkin LR, Allen PD, Gray AB,
Newland AC and Kelsey SM: Inhibition of autophagy abrogates tumour
necrosis factor alpha induced apoptosis in human T-lymphoblastic
leukaemic cells. Br J Haematol. 98:673–685. 1997. View Article : Google Scholar : PubMed/NCBI
|
9
|
González-Polo RA, Boya P, Pauleau AL,
Jalil A, Larochette N, Souquère S, Eskelinen EL, Pierron G, Saftig
P and Kroemer G: The apoptosis/autophagy paradox: Autophagic
vacuolization before apoptotic death. J Cell Sci. 118:3091–3102.
2005. View Article : Google Scholar : PubMed/NCBI
|
10
|
Tóth S, Nagy K, Pálfia Z and Réz G:
Cellular autophagic capacity changes during azaserine-induced
tumour progression in the rat pancreas. Up-regulation in all
premalignant stages and down-regulation with loss of cycloheximide
sensitivity of segregation along with malignant transformation.
Cell Tissue Res. 309:409–416. 2002. View Article : Google Scholar : PubMed/NCBI
|
11
|
Gozuacik D and Kimchi A: Autophagy as a
cell death and tumor suppressor mechanism. Oncogene. 23:2891–2906.
2004. View Article : Google Scholar : PubMed/NCBI
|
12
|
Mizushima N: Methods for monitoring
autophagy. Int J Biochem Cell Biol. 36:2491–2502. 2004. View Article : Google Scholar : PubMed/NCBI
|
13
|
Johnson CR and Jarvis WD: Caspase-9
regulation: An update. Apoptosis. 9:423–427. 2004. View Article : Google Scholar : PubMed/NCBI
|
14
|
Fan TJ, Han LH, Cong RS and Liang J:
Caspase family proteases and apoptosis. Acta Biochim Biophys Sin
(Shanghai). 37:719–727. 2005. View Article : Google Scholar
|
15
|
Li LW, Yu XY, Yang Y, Zhang CP, Guo LP and
Lu SH: Expression of esophageal cancer related gene 4 (ECRG4), a
novel tumor suppressor gene, in esophageal cancer and its
inhibitory effect on the tumor growth in vitro and in vivo. Int J
Cancer. 125:1505–1513. 2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Li L, Zhang C, Li X, Lu S and Zhou Y: The
candidate tumor suppressor gene ECRG4 inhibits cancer cells
migration and invasion in esophageal carcinoma. J Exp Clin Cancer
Res. 29:1332010. View Article : Google Scholar : PubMed/NCBI
Retraction. J Exp Clin Cancer Res.
30:192011. View Article : Google Scholar
|
17
|
Li LW, Li YY, Li XY, Zhang CP, Zhou Y and
Lu SH: A novel tumor suppressor gene ECRG4 interacts directly with
TMPRSS11A (ECRG1) to inhibit cancer cell growth in esophageal
carcinoma. BMC Cancer. 11:522011. View Article : Google Scholar : PubMed/NCBI
|
18
|
Baird A, Lee J, Podvin S, Kurabi A, Dang
X, Coimbra R, Costantini T, Bansal V and Eliceiri BP: Esophageal
cancer-related gene 4 at the interface of injury, inflammation,
infection, and malignancy. Gastrointest Cancer. 2014:131–142. 2014.
View Article : Google Scholar
|
19
|
You Y, Yang W, Qin X, Wang F, Li H, Lin C,
Li W, Gu C, Zhang Y and Ran Y: ECRG4 acts as a tumor suppressor and
as a determinant of chemotherapy resistance in human nasopharyngeal
carcinoma. Cell Oncol (Dordr). 38:205–214. 2015. View Article : Google Scholar
|
20
|
Matsuzaki J, Torigoe T, Hirohashi Y,
Kamiguchi K, Tamura Y, Tsukahara T, Kubo T, Takahashi A, Nakazawa
E, Saka E, et al: ECRG4 is a negative regulator of
caspase-8-mediated apoptosis in human T-leukemia cells.
Carcinogenesis. 33:996–1003. 2012. View Article : Google Scholar : PubMed/NCBI
|